EP
SNDX icon

Eversept Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Eversept Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.2M Sell
2,798,210
-87,412
-3% -$1.82M 3.17% 8
2026
Q1 		$67.4M Sell
2,885,622
-428,786
-13% -$9.32M 3.55% 8
2025
Q4 		$69.6M Sell
3,314,408
-152,906
-4% -$2.67M 3.51% 7
2025
Q3 		$53.3M Sell
3,467,314
-598,041
-15% -$7.83M 3.68% 6
2025
Q2 		$38.1M Sell
4,065,355
-146,915
-3% -$1.62M 3.5% 8
2025
Q1 		$51.7M Buy
4,212,270
+3,868,870
+1,127% +$54.6M 5.26% 5
2024
Q4 		$4.54M Sell
343,400
-3,761,913
-92% -$64.4M 0.4% 42
2024
Q3 		$79M Buy
4,105,313
+491,682
+14% +$10.2M 5.41% 6
2024
Q2 		$74.2M Buy
3,613,631
+480,518
+15% +$10.1M 5.08% 7
2024
Q1 		$74.6M Sell
3,133,113
-250,131
-7% -$5.58M 4.97% 7
2023
Q4 		$73.1M Buy
3,383,244
+786,999
+30% +$12.1M 6.42% 3
2023
Q3 		$37.7M Buy
2,596,245
+406,513
+19% +$7.69M 3.19% 8
2023
Q2 		$45.8M Sell
2,189,732
-19,325
-0.9% -$402K 3.83% 8
2023
Q1 		$46.7M Buy
2,209,057
+588,344
+36% +$14.6M 3.25% 8
2022
Q4 		$41.2M Buy
1,620,713
+409,279
+34% +$9.55M 3.61% 9
2022
Q3 		$29.1M Buy
1,211,434
+217,072
+22% +$4.87M 2.52% 11
2022
Q2 		$19.1M Buy
+994,362
New +$16.6M 1.36% 22

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Eversept Partners's SNDX Position: Q2 2026 in Review

Eversept Partners reduced its Syndax Pharmaceuticals (SNDX) stake by 3% in Q2 2026, selling an estimated $1.82M and leaving 2,798,210 shares worth $61.2M. The position accounts for 3.17% of the portfolio, ranked #8.

Eversept Partners first reported a position in SNDX in Q2 2022 and has held it in 17 quarters since. The position peaked at $79M in Q3 2024. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Eversept Partners held 2,798,210 shares of Syndax Pharmaceuticals worth $61.2M as of Q2 2026.
  • Eversept Partners sold 87,412 Syndax Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
  • Syndax Pharmaceuticals made up 3.17% of Eversept Partners's portfolio in Q2 2026, its #8 holding.
  • Eversept Partners first reported a position in Syndax Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Eversept Partners's Syndax Pharmaceuticals position peaked at $79M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.